UnitedHealth Group Best Performer in the DJIA So Far Today — Data Talk
UnitedHealth Group Incorporated (UNH) is currently at $499.84, up $20.85 or 4.35%
--Would be highest close since Feb. 27, 2024, when it closed at $513.42
--Currently up four consecutive days; up 13.81% over this period
--Longest winning streak since Jan. 4, 2024, when it rose for six straight trading days
--Best four day stretch since the four days ending Nov. 5, 2020, when it rose 16.14%
--Up 1.04% month-to-date
--Down 5.06% year-to-date
--Down 9.96% from its all-time closing high of $555.15 on Oct. 31, 2022
--Up 2.54% from 52 weeks ago (April 20, 2023), when it closed at $487.46
--Down 9.61% from its 52-week closing high of $552.97 on Nov. 30, 2023
--Up 13.81% from its 52-week closing low of $439.20 on April 12, 2024
--Traded as high as $502.00; highest intraday level since Feb. 27, 2024, when it hit $525.59
--Up 4.8% at today's intraday high
--Best performer in the DJIA today
--Fourth best performer in the S&P 500 today
--Contributed 136.98 points to the DJIA so far today
All data as of 10:37:27 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 18, 2024 10:55 ET (14:55 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?